$NBRV GLTA!!! this company should become a subsrantial driver of the antibiotic industry. I was sceptical about the ability to progress, and partially still i am, but being invested heavilly here, wold rather grant aditional 6 months period till the years end. Looks the SP is badly manipzlated and the fear of the decision on 29.7. is additional gain stoper. Honestly, i hope there won't be a RS by the end of the year and the SP will run above $1 to regain listing requirement w/o the need of a RS. summer time-holiday time-second wave covid19 time. The months ahead will pave the way! Enjoy the splendid sunday evening!